Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel Fumarate Hydratase Mutation in Siblings With Early Onset Uterine Leiomyomas and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome.
|
28700432 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) represents an autosomal dominant syndrome that results from a germline mutation in fumarate hydratase gene (FH).
|
30171332 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Inactivating FH germline mutations are found in patients with hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome comprising benign cutaneous/uterine leiomyomas and renal cell carcinoma.
|
29339836 |
2018 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
The overall sensitivity and specificity of absent FH expression in leiomyomas for detection of patients with HLRCC were 70.0% and 97.6%, respectively.
|
28288038 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous germline mutations in the FH gene predispose to an aggressive autosomal dominant inherited early-onset kidney cancer syndrome: hereditary leiomyomatosis and renal cell cancer (HLRCC).
|
28747166 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Patients with hereditary leiomyomatosis and renal cell carcinoma (HLRCC) resulting from fumarate hydratase (FH) mutations may present with skin, uterine, and renal tumors, with each having unique pathologic features.
|
28171700 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
CTD_human |
Germ line mutations of the gene encoding the tricarboxylic acid (TCA) cycle enzyme fumarate hydratase (<i>FH</i>) cause a hereditary cancer syndrome known as hereditary leiomyomatosis and renal cell cancer (HLRCC).
|
28289076 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Multiple cutaneous leiomyomas leading to discovery of novel splice mutation in the fumarate hydratase gene associated with HLRCC.
|
28266706 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
Germ line mutations of the gene encoding the tricarboxylic acid (TCA) cycle enzyme fumarate hydratase (<i>FH</i>) cause a hereditary cancer syndrome known as hereditary leiomyomatosis and renal cell cancer (HLRCC).
|
28289076 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant manifestation of cutaneous and uterine leiomyomas together with renal cancer due to autosomal dominant germline mutations of fumarate hydratase gene.
|
29267457 |
2017 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
Ten of the 13 lesions from patients with HLRCC syndrome showed negative FH staining.
|
27097334 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the tricarboxylic acid cycle enzyme fumarate hydratase cause hereditary leiomyomatosis and renal cell cancer.
|
27580029 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant tumor susceptibility syndrome, and the disease-related gene has been identified as fumarate hydratase (fumarase, FH).
|
26983443 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome secondary to germline fumarate hydratase (FH) mutation presents with cutaneous and uterine leiomyomas, and a distinctive aggressive renal carcinoma.
|
26574848 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
An emerging group of high-grade renal cell carcinomas (RCCs), particularly carcinomas arising in the hereditary leiomyomatosis renal cell carcinoma syndrome (HLRCC), show fumarate hydratase (FH) gene mutation and loss of function.
|
27635946 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome).
|
26945337 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
|
26900816 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel splice site mutation in the fumarate hydratase (FH) gene is associated with multiple cutaneous leiomyomas in a Japanese patient.
|
26173633 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Identification of a family with hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome and a novel mutation in the FH gene.
|
26493120 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Somatic MED12 mutations and biallelic FH inactivation are mutually exclusive in both HLRCC syndrome-associated and sporadic uterine leiomyomas.
|
27187686 |
2016 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is a rare autosomal dominant disorder characterized by fumarate hydratase (FH) gene mutation.
|
26637880 |
2015 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to evaluate the ability of morphology and IHC for FH and 2SC to help identify HLRCC in young patients with uterine smooth muscle tumors.
|
26457356 |
2015 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation.
|
26237645 |
2015 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We corroborated previously reported FH mutations in nine out of the 18 HLRCC-associated UL cases and identified two missense mutations in FH in only two nonsyndromic UL cases and one control.
|
26113603 |
2015 |
Hereditary Leiomyomatosis and Renal Cell Cancer
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The clinical diagnosis of hereditary leiomyomatosis and renal cell cancer was corroborated by the identification of a heterozygous variant on exon 5 of the fumarate hydratase gene (c.578C>T p.T193I).
|
24346898 |
2014 |